“…[12] In particular, 3-aminoquinoxalin-2(1H)-ones as an important subfamily has appeared in numerous bioactive compounds such as histamine-4 receptor antagonists, [13] modulator of PAS kinase, [14] ataquimast, [15] and epsteine-barr virus inhibitor (Figure 1). [16] In this context, the direct C(sp 2 )À H amination, [17] amidation, [18] and sulfonation [19] reactions of quinoxalin-2(1H)-ones using primary or secondary amines, amides and NH-sulfoximines as the effective amino source have been explored in recent years. Several outstanding progresses have been achieved by the groups of Cui, [17a] Qu, [18] Yotphan [19b] and et al In 2019, Zhang and co-workers introduced the amination of quinoxalin-2(1H)-ones with TMSN 3 to construct primary 3-aminoquinoxalin-2(1H)-ones by employing stoichiometric Ce(NH 4 ) 2 (NO 3 ) 6 as an oxidant (Scheme 1d).…”